Status:
WITHDRAWN
Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Chronic Myeloid Leukemia
Eligibility:
All Genders
55+ years
Phase:
PHASE1
PHASE2
Brief Summary
Donors with CM will be solicited from a waiting list of patients awaiting BMT from the waiting list of MUD searches. Maximally matched donor will be searched for each eligible CML patient with a goal...
Eligibility Criteria
Inclusion
- Patients above the age of 55 consenting to participate in the study.
- Patients with documented CML with Philadelphia chromosome t (9:21)
- Patients with no HLA matched sibling.
- Patients eligible for BMT for who no matched unrelated donor can be identified after completion of an international donor search lasting for more than six months, or patients that have failed BMT.
- Patients with contra-indication to BMT.
- Patients refusing BMT.
- Patients who failed interferon alpha, ARAc and/or Glivec.
Exclusion
- Patients requiring immunosuppressive therapy or corticosteroids.
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00162513
Start Date
December 1 2006
Last Update
April 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91120